United States Competent Cells Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Competent Cells Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Competent Cells Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Competent Cells Overall Market Size
2.1 United States Competent Cells Market Size: 2021 VS 2027
2.2 United States Competent Cells Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Competent Cells Players in United States Market
3.2 Top United States Competent Cells Companies Ranked by Revenue
3.3 United States Competent Cells Revenue by Companies
3.4 Top 3 and Top 5 Competent Cells Companies in United States Market, by Revenue in 2020
3.5 Companies Competent Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Competent Cells Players in United States Market
3.6.1 List of Tier 1 Competent Cells Companies in United States
3.6.2 List of Tier 2 and Tier 3 Competent Cells Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Competent Cells Market Size Markets, 2021 & 2027
4.1.2 Chemically Competent Cells
4.1.3 Electrocompetent Cells
4.2 By Type - United States Competent Cells Revenue & Forecasts
4.2.1 By Type - United States Competent Cells Revenue, 2016-2021
4.2.2 By Type - United States Competent Cells Revenue, 2022-2027
4.2.3 By Type - United States Competent Cells Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Competent Cells Market Size, 2021 & 2027
5.1.2 Subcloning & Routine Cloning
5.1.3 Phage Display Library Construction
5.1.4 Toxic/Unstable DNA Cloning
5.1.5 High-Throughput Cloning
5.1.6 Protein Expression
5.1.7 Mutagenesis
5.1.8 Single-Stranded DNA Production
5.1.9 Bacmid Creation
5.1.10 Cre-Lox Recombination (PIR1/PIR2)
5.2 By Application - United States Competent Cells Revenue & Forecasts
5.2.1 By Application - United States Competent Cells Revenue, 2016-2021
5.2.2 By Application - United States Competent Cells Revenue, 2022-2027
5.2.3 By Application - United States Competent Cells Revenue Market Share, 2016-2027
6 Competent Cells Companies Profiles
6.1 Merck KGaA
6.1.1 Merck KGaA Company Details
6.1.2 Merck KGaA Business Overview
6.1.3 Merck KGaA Competent Cells Introduction
6.1.4 Merck KGaA Competent Cells Revenue in United States Market (2016-2021)
6.1.5 Merck KGaA Recent Developments
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Details
6.2.2 Thermo Fisher Scientific Business Overview
6.2.3 Thermo Fisher Scientific Competent Cells Introduction
6.2.4 Thermo Fisher Scientific Competent Cells Revenue in United States Market (2016-2021)
6.2.5 Thermo Fisher Scientific Recent Developments
6.3 Agilent Technologies
6.3.1 Agilent Technologies Company Details
6.3.2 Agilent Technologies Business Overview
6.3.3 Agilent Technologies Competent Cells Introduction
6.3.4 Agilent Technologies Competent Cells Revenue in United States Market (2016-2021)
6.3.5 Agilent Technologies Recent Developments
6.4 Takara Bio
6.4.1 Takara Bio Company Details
6.4.2 Takara Bio Business Overview
6.4.3 Takara Bio Competent Cells Introduction
6.4.4 Takara Bio Competent Cells Revenue in United States Market (2016-2021)
6.4.5 Takara Bio Recent Developments
6.5 Promega Corporation
6.5.1 Promega Corporation Company Details
6.5.2 Promega Corporation Business Overview
6.5.3 Promega Corporation Competent Cells Introduction
6.5.4 Promega Corporation Competent Cells Revenue in United States Market (2016-2021)
6.5.5 Promega Corporation Recent Developments
6.6 Beijing TransGen Biotech
6.6.1 Beijing TransGen Biotech Company Details
6.6.2 Beijing TransGen Biotech Business Overview
6.6.3 Beijing TransGen Biotech Competent Cells Introduction
6.6.4 Beijing TransGen Biotech Competent Cells Revenue in United States Market (2016-2021)
6.6.5 Beijing TransGen Biotech Recent Developments
6.7 GeneScript Corporation
6.7.1 GeneScript Corporation Company Details
6.7.2 GeneScript Corporation Business Overview
6.7.3 GeneScript Corporation Competent Cells Introduction
6.7.4 GeneScript Corporation Competent Cells Revenue in United States Market (2016-2021)
6.7.5 GeneScript Corporation Recent Developments
6.8 Yeastern Biotech
6.8.1 Yeastern Biotech Company Details
6.8.2 Yeastern Biotech Business Overview
6.8.3 Yeastern Biotech Competent Cells Introduction
6.8.4 Yeastern Biotech Competent Cells Revenue in United States Market (2016-2021)
6.8.5 Yeastern Biotech Recent Developments
6.9 New England Biolabs
6.9.1 New England Biolabs Company Details
6.9.2 New England Biolabs Business Overview
6.9.3 New England Biolabs Competent Cells Introduction
6.9.4 New England Biolabs Competent Cells Revenue in United States Market (2016-2021)
6.9.5 New England Biolabs Recent Developments
6.10 QIAGEN N.V.
6.10.1 QIAGEN N.V. Company Details
6.10.2 QIAGEN N.V. Business Overview
6.10.3 QIAGEN N.V. Competent Cells Introduction
6.10.4 QIAGEN N.V. Competent Cells Revenue in United States Market (2016-2021)
6.10.5 QIAGEN N.V. Recent Developments
6.11 OriGene Technologies
6.11.1 OriGene Technologies Company Details
6.11.2 OriGene Technologies Business Overview
6.11.3 OriGene Technologies Competent Cells Introduction
6.11.4 OriGene Technologies Competent Cells Revenue in United States Market (2016-2021)
6.11.5 OriGene Technologies Recent Developments
6.12 Lucigen
6.12.1 Lucigen Company Details
6.12.2 Lucigen Business Overview
6.12.3 Lucigen Competent Cells Introduction
6.12.4 Lucigen Competent Cells Revenue in United States Market (2016-2021)
6.12.5 Lucigen Recent Developments
6.13 Zymo Research
6.13.1 Zymo Research Company Details
6.13.2 Zymo Research Business Overview
6.13.3 Zymo Research Competent Cells Introduction
6.13.4 Zymo Research Competent Cells Revenue in United States Market (2016-2021)
6.13.5 Zymo Research Recent Developments
6.14 Bio-Rad Laboratories
6.14.1 Bio-Rad Laboratories Company Details
6.14.2 Bio-Rad Laboratories Business Overview
6.14.3 Bio-Rad Laboratories Competent Cells Introduction
6.14.4 Bio-Rad Laboratories Competent Cells Revenue in United States Market (2016-2021)
6.14.5 Bio-Rad Laboratories Recent Developments
6.15 Bioline
6.15.1 Bioline Company Details
6.15.2 Bioline Business Overview
6.15.3 Bioline Competent Cells Introduction
6.15.4 Bioline Competent Cells Revenue in United States Market (2016-2021)
6.15.5 Bioline Recent Developments
6.16 Delphi Genetics
6.16.1 Delphi Genetics Company Details
6.16.2 Delphi Genetics Business Overview
6.16.3 Delphi Genetics Competent Cells Introduction
6.16.4 Delphi Genetics Competent Cells Revenue in United States Market (2016-2021)
6.16.5 Delphi Genetics Recent Developments
6.17 IBA GmBH
6.17.1 IBA GmBH Company Details
6.17.2 IBA GmBH Business Overview
6.17.3 IBA GmBH Competent Cells Introduction
6.17.4 IBA GmBH Competent Cells Revenue in United States Market (2016-2021)
6.17.5 IBA GmBH Recent Developments
6.18 Cell Applications
6.18.1 Cell Applications Company Details
6.18.2 Cell Applications Business Overview
6.18.3 Cell Applications Competent Cells Introduction
6.18.4 Cell Applications Competent Cells Revenue in United States Market (2016-2021)
6.18.5 Cell Applications Recent Developments
6.19 BioDynamics Laboratory
6.19.1 BioDynamics Laboratory Company Details
6.19.2 BioDynamics Laboratory Business Overview
6.19.3 BioDynamics Laboratory Competent Cells Introduction
6.19.4 BioDynamics Laboratory Competent Cells Revenue in United States Market (2016-2021)
6.19.5 BioDynamics Laboratory Recent Developments
6.20 Scarab Genomics
6.20.1 Scarab Genomics Company Details
6.20.2 Scarab Genomics Business Overview
6.20.3 Scarab Genomics Competent Cells Introduction
6.20.4 Scarab Genomics Competent Cells Revenue in United States Market (2016-2021)
6.20.5 Scarab Genomics Recent Developments
6.21 GCC Biotech
6.21.1 GCC Biotech Company Details
6.21.2 GCC Biotech Business Overview
6.21.3 GCC Biotech Competent Cells Introduction
6.21.4 GCC Biotech Competent Cells Revenue in United States Market (2016-2021)
6.21.5 GCC Biotech Recent Developments
6.22 SMOBIO Technology
6.22.1 SMOBIO Technology Company Details
6.22.2 SMOBIO Technology Business Overview
6.22.3 SMOBIO Technology Competent Cells Introduction
6.22.4 SMOBIO Technology Competent Cells Revenue in United States Market (2016-2021)
6.22.5 SMOBIO Technology Recent Developments
6.23 Edge BioSystems
6.23.1 Edge BioSystems Company Details
6.23.2 Edge BioSystems Business Overview
6.23.3 Edge BioSystems Competent Cells Introduction
6.23.4 Edge BioSystems Competent Cells Revenue in United States Market (2016-2021)
6.23.5 Edge BioSystems Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Competent Cells Market Opportunities & Trends in United States Market
Table 2. Competent Cells Market Drivers in United States Market
Table 3. Competent Cells Market Restraints in United States Market
Table 4. Key Players of Competent Cells in United States Market
Table 5. Top Competent Cells Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Competent Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Competent Cells Revenue Share by Companies, 2016-2021
Table 8. Companies Competent Cells Product Type
Table 9. List of Tier 1 Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Competent Cells Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Competent Cells Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Competent Cells Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Competent Cells Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Competent Cells Revenue (US$, Mn), 2022-2027
Table 17. Merck KGaA Company Details
Table 18. Merck KGaA Business Overview
Table 19. Merck KGaA Competent Cells Product
Table 20. Merck KGaA Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Merck KGaA Recent Developments
Table 22. Thermo Fisher Scientific Company Details
Table 23. Thermo Fisher Scientific Business Overview
Table 24. Thermo Fisher Scientific Competent Cells Product
Table 25. Thermo Fisher Scientific Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Agilent Technologies Company Details
Table 28. Agilent Technologies Business Overview
Table 29. Agilent Technologies Competent Cells Product
Table 30. Agilent Technologies Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Agilent Technologies Recent Developments
Table 32. Takara Bio Company Details
Table 33. Takara Bio Business Overview
Table 34. Takara Bio Competent Cells Product
Table 35. Takara Bio Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Takara Bio Recent Developments
Table 37. Promega Corporation Company Details
Table 38. Promega Corporation Business Overview
Table 39. Promega Corporation Competent Cells Product
Table 40. Promega Corporation Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Promega Corporation Recent Developments
Table 42. Beijing TransGen Biotech Company Details
Table 43. Beijing TransGen Biotech Business Overview
Table 44. Beijing TransGen Biotech Competent Cells Product
Table 45. Beijing TransGen Biotech Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Beijing TransGen Biotech Recent Developments
Table 47. GeneScript Corporation Company Details
Table 48. GeneScript Corporation Business Overview
Table 49. GeneScript Corporation Competent Cells Product
Table 50. GeneScript Corporation Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. GeneScript Corporation Recent Developments
Table 52. Yeastern Biotech Company Details
Table 53. Yeastern Biotech Business Overview
Table 54. Yeastern Biotech Competent Cells Product
Table 55. Yeastern Biotech Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Yeastern Biotech Recent Developments
Table 57. New England Biolabs Company Details
Table 58. New England Biolabs Business Overview
Table 59. New England Biolabs Competent Cells Product
Table 60. New England Biolabs Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. New England Biolabs Recent Developments
Table 62. QIAGEN N.V. Company Details
Table 63. QIAGEN N.V. Business Overview
Table 64. QIAGEN N.V. Competent Cells Product
Table 65. QIAGEN N.V. Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. QIAGEN N.V. Recent Developments
Table 67. OriGene Technologies Company Details
Table 68. OriGene Technologies Business Overview
Table 69. OriGene Technologies Competent Cells Product
Table 70. OriGene Technologies Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. OriGene Technologies Recent Developments
Table 72. Lucigen Company Details
Table 73. Lucigen Business Overview
Table 74. Lucigen Competent Cells Product
Table 75. Lucigen Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Lucigen Recent Developments
Table 77. Zymo Research Company Details
Table 78. Zymo Research Business Overview
Table 79. Zymo Research Competent Cells Product
Table 80. Zymo Research Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Zymo Research Recent Developments
Table 82. Bio-Rad Laboratories Company Details
Table 83. Bio-Rad Laboratories Business Overview
Table 84. Bio-Rad Laboratories Competent Cells Product
Table 85. Bio-Rad Laboratories Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. Bio-Rad Laboratories Recent Developments
Table 87. Bioline Business Overview
Table 88. Bioline Company Details
Table 89. Bioline Competent Cells Product
Table 90. Bioline Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. Bioline Recent Developments
Table 92. Delphi Genetics Company Details
Table 93. Delphi Genetics Business Overview
Table 94. Delphi Genetics Competent Cells Product
Table 95. Delphi Genetics Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 96. Delphi Genetics Recent Developments
Table 97. IBA GmBH Company Details
Table 98. IBA GmBH Business Overview
Table 99. IBA GmBH Competent Cells Product
Table 100. IBA GmBH Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 101. IBA GmBH Recent Developments
Table 102. Cell Applications Company Details
Table 103. Cell Applications Business Overview
Table 104. Cell Applications Competent Cells Product
Table 105. Cell Applications Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 106. Cell Applications Recent Developments
Table 107. BioDynamics Laboratory Company Details
Table 108. BioDynamics Laboratory Business Overview
Table 109. BioDynamics Laboratory Competent Cells Product
Table 110. BioDynamics Laboratory Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 111. BioDynamics Laboratory Recent Developments
Table 112. Scarab Genomics Company Details
Table 113. Scarab Genomics Business Overview
Table 114. Scarab Genomics Competent Cells Product
Table 115. Scarab Genomics Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 116. Scarab Genomics Recent Developments
Table 117. GCC Biotech Company Details
Table 118. GCC Biotech Business Overview
Table 119. GCC Biotech Competent Cells Product
Table 120. GCC Biotech Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 121. GCC Biotech Recent Developments
Table 122. SMOBIO Technology Company Details
Table 123. SMOBIO Technology Business Overview
Table 124. SMOBIO Technology Competent Cells Product
Table 125. SMOBIO Technology Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 126. SMOBIO Technology Recent Developments
Table 127. Edge BioSystems Company Details
Table 128. Edge BioSystems Business Overview
Table 129. Edge BioSystems Competent Cells Product
Table 130. Edge BioSystems Competent Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 131. Edge BioSystems Recent Developments
List of FiguresFigure 1. Competent Cells Segment by Type
Figure 2. Competent Cells Segment by Application
Figure 3. United States Competent Cells Market Overview: 2020
Figure 4. United States Competent Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Competent Cells Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Competent Cells Revenue in 2020
Figure 7. By Type - United States Competent Cells Revenue Market Share, 2016-2027
Figure 8. By Application - United States Competent Cells Revenue Market Share, 2016-2027
Figure 9. Merck KGaA Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Thermo Fisher Scientific Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Agilent Technologies Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Takara Bio Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Promega Corporation Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Beijing TransGen Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. GeneScript Corporation Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Yeastern Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. New England Biolabs Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. QIAGEN N.V. Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. OriGene Technologies Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Lucigen Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Zymo Research Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Bio-Rad Laboratories Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bioline Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Delphi Genetics Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. IBA GmBH Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Cell Applications Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. BioDynamics Laboratory Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Scarab Genomics Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. GCC Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. SMOBIO Technology Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Edge BioSystems Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)